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Book Reviews
Editorial Announcement
The review of the book 'Urological Oncology' edited
by Waxman and Williams which appears below
replaces the incorrect review published in the British
Journal of Cancer in January 1993. The review pub-
lished in January did, in fact, relate to a different book
'Urological Oncology - Dilemmas and Developments'
edited by A.R. Alderson et al. and published by John
Wiley & Son.
Urological Oncology
Edited by J. Waxman & G. Williams, Sevenoaks, Kent:
Edward Arnold, 1992 252 pp. £49.50.
With the rapid advances in many areas of urology, the
publication of a state-of-the-art survey of urological onco-
logy is long overdue. Great progress has been made in a
number of areas of urological oncology, especially in the
treatment of tumours of the prostate, bladder and testis. The
editors are to be congratulated for bringing together authori-
tative contributions from acknowledged experts in this
difficult field of urology.
The information presented reinforces the widely-held belief
that cancer treatment in urology should be performed in
specialist centres and that there are many questions currently
left unanswered. It is refreshing to see both sides of the
argument concerning radical treatment of early prostate
cancer although claims, in the introduction, that patients can
be cured of advanced bladder cancer by combination chemo-
therapy are not borne out by the text. One or two things
niggle, however; the chapter on surgery for Stage I testicular
cancer is not, in truth, about Stage I cancer but about
surgical lymphadenectomy since a significant proportion of
patients are upstaged (to Stage II) following surgery and
there are still no firm conclusion to be drawn about the
timing of inguinal lymph node dissection in penile carcinoma.
Much emphasis has been placed by the authors on patient
selection for treatment, on optimal timing for treatment and
on minimisation of toxicity with guidelines on patient selec-
tion; all too often the need to obtain information from
clinical trials overshadows the individual needs of the patient.
However, prospects for the future are well-covered with sec-
tions on molecular biology, oncogenes and identification of
peptide antagonists of tumour growth factors; and the rela-
tively new concept of chemoembolisation for advanced
tumours of the kidney will stimulate a great deal of interest
in oncological circles.
The book is sparsely illustrated but this does not detract
from its overall value. The text is widely referenced to a high
standard with most of the current literature in oncological
advances cited and all urologists will find further stimulation
from following up the listings. This volume should certainly
be on the shelves of all urologists, regardless of whether they
practice as cancer specialists and the informative nature of
the text, with opposing arguments carefully laid out, should
encourage more junior surgeons to delve within for a balanc-
ed assessment of current thinking in urological cancer
therapy. With a surge in oncologists' interest directed
towards oncogenes and genetic manipulation for cancer treat-
ment, we can all look forward to updates of this volume
which has set the baseline for the exciting developments in
urological cancer treatment which are surely just over the
horizon.
N. Bullock
Cancer in Children. Clinical Management. 3rd Edition
Edited by P.A. Vofite, A. Barrett & J. Lemerle, Heidelberg:
Springer-Verlag, 1992, 365 pp. 148,00 DM.
The second edition of this book appeared in 1986 and was
one of the only textbooks on paediatric oncology which
described European experience and treatment strategies. At
that time, as to some extent is still the case, the majority of
textbooks had a major American bias. The UICC book
therefore provided an invaluable and up to date reference
source for the increasing number of paediatricians who at
that time were entering this subspeciality. The new 'Com-
pletely Revised Edition' appears 6 years later, but still com-
pressed into the same 365 pages. Over the past decade there
have been significant advances, not only in the outcome in a
number of childhood cancers, but also in our understanding
of the biology of these rare tumours. To what extent does
this new edition reflect these advances?
The overall layout of the book follows convention, with
initial general chapters covering areas such as aetiology,
cytogenetics and infections. The succinct chapter on radiation
therapy is of particular use to a readership which may have
little experience in this field. More detail on the theory of
methods of delivering radiotherapy with regard to rate and
fractionation would have been of interest.
In an expanded chapter on cancer chemotherapy, mechan-
isms and toxicity are discussed with a brief consideration of
drug pharmacokinetics. It is a little surprising to not see any
mention of formula based dose individualisation for carbo-
platin, which is an important advance over empirical dose
prescription. The slightly misleading terminology when de-
scribing drug schedules should be noted. The term 'for 3
weeks' appears repeatedly, where it should read 'every 3
weeks'.
A short chapter considers the place of surgery, although as
in the case of the section on application of radiotherapy, to a
large extent these issues are considered in the disease related
sections.
The chapter on the late sequelae reviews the increasing
body of data regarding growth, neurological and other organ
toxicity. It would have been useful to have had the authors'
firm views on the indications for growth hormone in
leukaemia patients and the frequency and nature of follow-
up in children who have had anthracycline or bleomycin - all
practical issues.
The section on ALL overviews the German BFM experi-
ence and current protocols. One of the particular values of
the UICC book is to provide data from the BFM group,
which is often difficult to find in print elsewhere.
As in the previous edition, the arguments for and against
elective bone marrow transplantation are reviewed in a
balanced manner and useful tables of relative indications are
given for a variety of clinical scenarios.
Separate chapters cover B cell and T cell NHL. With the
increasing unification of immunohistological classifications
for childhood NHL it is now probably inappropriate to
separate these in this manner. In neither chapter is a com-
pletely satisfactory histological classification system de-
scribed. There is an urgent need for paediatricians to produce
a consensus system, probably a modified Kiel classification,
in order to avoid the recurring problem of people talking at
crossed purposes.
In the section on Hodgkin's disease, which provides an
excellent overview of current treatment strategies, it would
again have been of interest to have the authors' views on the
optimum treatment stage by stage, in terms of balance
between chemotherapy and radiotherapy. Some of the newer
non-sterilising chemotherapy regimens are also omitted from
this discussion.
Although rare, the malignant germ cell tumours of child-1442 BOOK REVIEWS
hood are a group in which spectacular advances in cure rates
have been made since the introduction of cisplatin based
chemotherapy regimens. In an otherwise most informative
section there seems little value in a large table describing
three VAC based treatments, as these are now largely redun-
dant. The addition of the more recently developed carbo-
platin based regimen would seem more appropriate.
Brain tumours remain an area where advances have been
disappointing and the logic for including a survival curve
apparently showing a striking advantage to receiving
chemotherapy in medulloblastoma is unclear when in the text
it states that full analysis shows little, if any, benefit.
The chapter on neuroblastoma appears to have changed
disappointingly little since the previous edition. Almost two
pages are devoted to interpretation of urinary catecholamine
analysis, with less than half a page to an overview of
chemotherapy strategies. Reference to the outmoded use of
bleomycin or prednisolone in this tumour seems irrelevant
and more detailed consideration of the potential value of
high dose intensity induction regimens or drug scheduling
strategies might have been of value. One major criticism is
the continued use of both the TNM or the Evans
classification. It is now a few years since a consensus publica-
tion agreeing on the International Neuroblastoma Staging
System was published and it appears retrogressive to not
present this sytem as the single one to be recommended. The
major advances made in patients with stage 3 unresectable
disease due to effective intensive chemotherapy are under-
stated and the treatment strategies which have achieved this
improvement could have been further considered. A little
more speculation on the impact of molecular biology on the
understanding of neuroblastoma would have been welcome
considering the amount of data being produced on the
significance of oncogene amplification, ploidy and cytogenetic
abnormalities.
While it is entirely appropriate that a section on liver
tumours should be authored by a paediatric hepatic surgeon,
this has resulted in an understatement of the importance of
primary chemotherapy. Few paediatric oncologists would
now recommend the sort of aggressive primary surgery that
is described. With the effective platinum based regimens now
in use this aggressive approach is often counter-productive.
Also to suggest that 'prophylactic' chemotherapy should be
withheld for up to 2 months after surgery in those with
operable tumours is ill advised and few would feel that
chemotherapy has a significant adverse effect on liver
regeneration which outweighed the need for early adjuvant
chemotherapy.
As in the previous edition, one of the most useful sections
is that on some of the rarer tumours found in childhood with
references providing advice for the occasion when one is
faced with these unusual tumours.
It is a little surprising not to find a section dealing with
symptom care and approaches to palliative therapy. Even
with effective multi-modality treatment around 40% of child-
ren will die of their disease and supportive care, now often
provided at home, is a major part of the work of any
children's cancer unit.
In summary, this concise book provides an often excellent
overview of current management of children's cancer. Some
sections would have benefitted from a little more revision and
updating, but overall it provides a very useful and affordable
basic text for anyone entering the speciality.
C.R. Pinkerton
Bowel Cancer. The Facts
J.M.A. Northover & J.D. Kettner, Oxford: OUP, 1992,
193 pp. £35.00 Hardback, £15.00 Paperback.
Whilst the imaginary man on top of the Clapham omnibus
has a one in twenty-five possibility of developing bowel
cancer, this book, written for the 'lay public', is unlikely to
be high on his reading list. This is unfortunate as the
majority of patients with bowel cancer have been sympto-
matic for more than 6 months and 30% present as emergencies
with obstruction or perforation. This late presentation un-
doubtedly worsens the prognosis.
The authors state that the book is written primarily for
those without previous knowledge or expertise in the health
sciences and there are extensive explanations of medical ter-
minology and basic medical sciences. There are chapters
covering the anatomy, physiology and embryology of the
bowel, the pathology and aetiology of bowel cancer, presen-
tation and investigation of bowel symptoms and finally the
treatment of bowel cancer. These topics are comprehensively
covered with discussion of a number of recent studies; unfor-
tunately references for these papers are not given,
presumably because the book is aimed at a lay public,
though that does not seem to be an appropriate reason. The
chapter on surgery for bowel cancer at 36 pages would not
be amiss in a textbook of surgery! Treatment by other
modalities (radiotherapy, chemotherapy, immunotherapy and
lasers) is succinctly discussed, however this is a fast moving
field and therapy with both radiotherapy and combination
chemotherapy with 5-fluorouracil and levamisole will have an
increasingly important role to play in the management of
bowel cancer.
The prognosis following treatment of early bowel cancer is
excellent (97% 5 year survival for Duke's Stage A) and the
role of this book should be to educate doctors, particularly
general practitioners, nurses and paramedical staff to recog-
nise the early symptoms of bowel cancer and refer the patient
for investigation and treatment. Not infrequently, patients
are seen who have received prolonged iron therapy for
anaemia which has not been investigated and when finally
referred to a specialist an inoperable bowel cancer is found.
The hopes for the future are that (a) detection of occult
neoplasms by population screening will prove worthwhile
and the section on 'Prevention and screening' is a good
overview of the problems and possible solutions and (b) the
concept that modification of the Western diet to a low fat/
high fibre 'hunter-gatherer' diet may reduce the incidence of
bowel cancer to a level found in African villagers, this over-
simplification is explored in the chapter on 'The causes of
bowel cancer'.
The chapter on 'The symptoms ofbowel cancer and when to
go to the doctor' is perhaps the most important for the lay
reader highlighting the symptoms of: bleeding per rectum,
change in bowel habit, abdominal pain, tenesmus and general
symptoms of weight loss, loss of appetite and anaemia. This
should be the basis for educational material to improve
public awareness of early symptoms, although overcoming
the dual taboos of cancer and bowels will remain a for-
midable hurdle.
If this book is not on the reading list of the man on the
Clapham omnibus, it should certainly be read by his general
practitioner and by medical, nursing and paramedical staff
caring for patients with bowel cancer. The series of 'The
Facts' books includes 36 other titles suggesting commercial
success, perhaps they are best sellers in Clapham bookstores!
St.J. Collier